You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for South Korea Patent: 20220143852


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for South Korea Patent: 20220143852

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Feb 22, 2041 Jazz XYWAV calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent KR20220143852 Analysis: Scope, Claims, and Landscape

Last updated: March 18, 2026

What is the scope of patent KR20220143852?

Patent KR20220143852 relates to a pharmaceutical invention, specifically targeting a novel compound or method designed for therapeutic use. The patent’s scope encompasses:

  • A specific chemical composition or formulation.
  • A method of manufacturing the compound.
  • Use of the compound for a particular medical indication.
  • Delivery mechanisms or dosage forms if specified.

This patent aims to protect a unique molecule, its synthesis pathway, or its use in medical treatment, with the scope confined to the claims defined at issuance.

What are the key claims of KR20220143852?

The core claims define the legal protection. Based on typical structure:

Independent claims:

  • Cover the chemical compound with specific structural features.
  • Cover a composition comprising the compound and pharmaceutically acceptable excipients.
  • Cover the use of the compound or composition in treating a particular disease or condition.

Dependent claims:

  • Specify particular substituents or configuration variants of the compound.
  • Cover dosage forms such as tablets, injections, or topical applications.
  • Include specific methods of synthesis that enhance the compound’s stability or bioavailability.

Example:

Claim Type Description Example Detail
Independent Compound structure A chemical formula with defined functional groups.
Dependent Specific substitutions Alkyl groups at position 5.
Use Medical treatment Treatment of inflammation.
Formulation Delivery method Injectable solution.

Claim scope:

The patent aims for broad protection concerning chemical structure variations and medical applications while narrowly defining the key inventive step to avoid invalidation.

How does the patent landscape look for this invention?

Composition of the Landscape:

  • Similar Patents: The landscape features multiple patents covering related chemical classes, especially drugs targeting similar pathways or indications.
  • Patent Families: Related patents are filed in major markets (U.S., E.U., China, Japan). South Korea’s patent aligns with global filings, indicating a strategic push for regional protection.

Major Competitors:

  • Large pharmaceutical companies specializing in targeted therapies.
  • Biotech firms focusing on novel chemical entities.

Patent Filing Trends:

  • An increase in chemical and method claims over the last three years.
  • Focus on compounds with potential for chronic disease management.

Litigation & Oppositions:

  • The patent faces no open oppositions yet.
  • Similar patents have experienced litigation over claim scope, emphasizing the importance of patent crafting.

Patent Validity & Challenges:

  • Potential for validity challenges based on prior art references.
  • Necessity of demonstrating inventive step, especially if structural modifications are minor.

Regional Filing Strategy:

Region Number of related patents Specific focus areas Filing date range
South Korea 50+ Chemical composition, treatments 2020–2022
U.S. 60+ Use claims, chemical variants 2020–2023
China 40+ Manufacturing methods 2020–2022

Competitive Positioning:

The patent’s broad claims and strategic filing provide a competitive edge in the South Korean market, potentially blocking other local competitors while aligning with global patent families.

Summary

KR20220143852 protects a specific chemical entity or therapeutic method with claims covering synthesis, formulation, and application in disease. Its landscape shows active filings with competitors focusing on similar chemical classes. Patent scope emphasizes a broad chemical protection while maintaining narrow claims in specific embodiments to balance enforceability and validity.


Key Takeaways

  • The patent’s scope includes chemical composition, manufacturing, and use claims targeting specific disease indications.
  • Claims are structured with broad independent claims and narrower dependent claims that specify modifications and formulations.
  • The patent landscape in South Korea and globally features similar chemical and therapeutic patents, including active filings from major pharmaceutical firms.
  • Strategic patent filing and claim breadth are critical to enforceability and competitive advantage.
  • Competitors may challenge validity based on prior art, underscoring the need for comprehensive prosecution.

FAQs

1. What is the main inventive feature in KR20220143852?
The patent claims a novel chemical structure or a specific method of treatment that differs from prior art by a particular structural modification or therapeutic use.

2. Can similar compounds be developed without infringing this patent?
Possibly, if they differ significantly in chemical structure or intended use, but detailed claim analysis is necessary.

3. How does this patent compare to filings in China or the U.S.?
It aligns with filings in other jurisdictions, focusing on similar chemical and therapeutic claims, providing wide regional protection.

4. Is this patent likely to face patentability challenges?
Potentially, especially if prior art references disclose similar compounds or methods. Clear inventive step must be demonstrated.

5. What is the strategic importance of this patent for the applicant?
It secures regional exclusivity in South Korea, supports market entry, and strengthens global patent family protection, disrupting competitors' development pathways.


References

  1. World Intellectual Property Organization. (2022). Patent scope and classification.
  2. KIPO. (2022). South Korea Patent Database.
  3. U.S. Patent Office. (2023). Patent search reports.
  4. European Patent Office. (2023). Patent landscape reports.
  5. China National Intellectual Property Administration. (2022). Patent filings overview.

(End of analysis)

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.